Consideration for Use of Novel Agents in Acute Myeloid Leukemia
There is a need for improved therapeutic strategies to combat AML disease progression.  Recent developments have expanded treatment options for acute myeloid leukemia (AML) including targeted agents, antibody-drug conjugates and novel formulations.
  • Acute Myelogenous Leukemia
  • Recorded Webcast
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation